Synovex H 20 mg Implant is a Health Canada–registered veterinary drug (DIN 00262064) held by Zoetis Canada Inc, containing Estradiol Benzoate. Health Canada lists its status as Dormant (status date 06 Jul 2026). Nexara Health has matched 29 registrations of Estradiol Benzoate across 2 other regulated markets.
Health Canada registration
| DIN | 00262064 |
|---|---|
| Brand name | Synovex H |
| Active ingredient | Estradiol Benzoate |
| Strength | 20 mg |
| Dosage form | Implant |
| Route | Subcutaneous |
| Company | Zoetis Canada Inc |
| Status | Dormant — 06 Jul 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | 40:12.00 |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Marketed | Dormant |
| 2026-09-03 | Status | Marketed | Dormant |
Estradiol Benzoate registered in other markets
29 registrations of the same molecule in 2 national registries outside Canada (first 11 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Taiwan | Eremon Injection | 聯邦化學製藥股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Eshormon Injection | 新喜國際企業股份有限公司 | 注射劑 | 已註銷 | TFDA | |
| Taiwan | Eshormon Suspended Injection "T.s." | 德星製藥廠有限公司 | 滅菌懸液注射劑 | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Roussel Uclaf | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Aventis Pharma S.a. | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Roussel Uclaf | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate | Bayer AG | （粉） | 已註銷 | TFDA | |
| Taiwan | Estradiol Benzoate "Diosynth" | Diosynth B.v. | （粉） | 已註銷 | TFDA | |
| United States | estradiol benzoate | zhejiang xianju pharmaceutical co., Ltd. | Powder | FDA NDC | ||
| United States | Estradiol benzoate | Bayer AG | Powder | FDA NDC | ||
| United States | Estradiol benzoate | Valdepharm | Powder | FDA NDC |
See every manufacturer of Estradiol Benzoate worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Synovex H (DIN 00262064) marketed in Canada?
No. Health Canada lists DIN 00262064 as Dormant as of 06 Jul 2026.
Who holds the Canadian licence for this product?
Zoetis Canada Inc is the company of record in the Health Canada Drug Product Database.
Is Estradiol Benzoate registered outside Canada?
Yes — Nexara Health has matched 29 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00262064, status date 2026-07-06; national medicine registries: FDA NDC, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00262064, status date 2026-07-06; national medicine registries: FDA NDC, TFDA.
Health Canada Drug Product Database (DPD), DIN 00262064, status date 2026-07-06; national medicine registries: FDA NDC, TFDA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.